DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Tang QJ, Lei HP, Wu H. et al.
Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy.
Acta Pharmacol Sin 2019;
40 (02) 208-215
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.